- Research works
- 4 ▲ 96% vs 2013–17
- Citations
- 31 8.7 per fractional work
- Top-10% rate
- 26.4% record average 16.5%
- Open access
- 77% world 28%
Not ranked overall: Rare Cancers Australia is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which research topics does Rare Cancers Australia publish most on?
By volume in 2022–2025: BRCA gene mutations in cancer, Nutrition, Genetics, and Disease, Genetic factors in colorectal cancer and Genetics, Bioinformatics, and Biomedical Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 BRCA gene mutations in cancer Genetics 0 works
- 2 Nutrition, Genetics, and Disease Genetics 0 works
- 3 Genetic factors in colorectal cancer Pathology and Forensic Medicine 0 works
- 4 Genetics, Bioinformatics, and Biomedical Research Molecular Biology 0 works
- 5 Mental Health and Patient Involvement General Health Professions 0 works
- 6 Cancer Genomics and Diagnostics Cancer Research 0 works
- 7 Childhood Cancer Survivors' Quality of Life Pediatrics, Perinatology and Child Health 0 works
- 8 Ethics in Clinical Research Public Health, Environmental and Occupational Health 0 works
- 9 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 0 works
- 10 Cancer survivorship and care Oncology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Rare Cancers Australia's research output changed?
Output in 2018–2022 was 96% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Bowral
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.